Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amelia Saul, PhD, CTRS, BCB
With
University of Puerto Rico
Cardiovascular disease (CVD) is the leading cause of death in the United States, disproportionately affecting racial and ethnic minority populations. Chronic stress has been identified as a significant risk factor for CVD, yet few interventions address stress reduction as a preventative measure. This study investigates whether HRV biofeedback training can serve as an effective, non-pharmacological intervention to improve stress resilience and reduce risk factors associated with CVD.
Age
18–35
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Adults
Age 18 to 35 years
Cognitively intact to follow instructions
English-speaking
Family history of cardiovascular disease.
You may not be if
Cognitive impairments that inhibit understanding instruction
Current diagnosis of hypertension that is controlled with prescribed medication
Previously receiving biofeedback training
Having a severe medical condition (e.g., pacemaker, cardiac arrhythmia, hypertension, diabetes)
Being actively psychotic
Having a neurological condition (e.g., Parkinson's disease) that would complicate the interpretation of physiological data
Patients currently taking medications such as MAOIs, alpha/beta-blockers, or withdrawal or maintenance medications (e.g., Librium, methadone) are excluded due to their potential to affect the HRV data